17 April 2015 - US-based medical technology company ConforMIS, Inc. has entered into license agreements with each of Wright Medical Technology, Inc. and with MicroPort Orthopedics, Inc., settling patent disputes, the company said on Friday.

These agreements resolve the patent disputes that originated between ConforMIS and Wright in September 2013.

ConforMIS has granted to MicroPort a non-exclusive, worldwide license under its patent portfolio for the use of certain patient-specific instrumentation in the implantation of non-patient-specific knee devices.

Specifically, ConforMIS has granted a license that covers MicroPort's Prophecy Patient-Specific Instrumentation system for use with the Advance and Evolution total knee replacement systems, including both the pin alignment and the resection versions of the Prophecy PSI, which MicroPort acquired from Wright during the pendency of the dispute.

Additionally, ConforMIS has granted to Wright a non-exclusive, worldwide license under its patent portfolio for the use of patient-specific instrumentation in the implantation of implants in the foot and ankle, other than patient-specific implants.

This license to Wright covers, among other things, Wright's Prophecy PSI for use with Wright's InBone and Infinity total ankle replacement systems.

ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient's unique anatomy.

It offers a line of customised knee implants designed to restore the natural shape of a patient's knee.

In recent clinical studies, iTotal CR, ConforMIS' cruciate-retaining total knee replacement implant and best-selling product, demonstrated superior clinical outcomes, including better function and greater patient satisfaction compared to traditional, off-the-shelf implants.

ConforMIS owns or exclusively in-licenses approximately 470 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints and other elements of the iFit Image-to-Implant technology platform.

The company believes its iFit Image-to-Implant technology platform has application to other major joints in the worldwide market for joint replacement products.